News | Womens Cardiovascular Health | June 23, 2022

Treatment for Heart Attacks Improving but Gaps in Access Persist, New Study Shows

Despite overall improvements to care for a heart attack, women are less likely to receive timely treatment, according to a new study in Annals of Emergency Medicine

Getty Images


June 23, 2022 — Despite overall improvements to care for a heart attackwomen are less likely to receive timely treatment, according to a new study in Annals of Emergency Medicine

“Heart attack treatments have come a long way but timely access to appropriate care is still an issue, especially for female patients,” said Juan Carlos Montoy, MD, PhD, assistant professor, University of California San Francisco Department of Emergency Medicine, and lead study author. 

This study analyzed more than 450,000 records of patients with one of two types of heart attack, an ST-elevation myocardial infarction (STEMI), or a non-ST-elevation myocardial infarction (NSTEMI), from 2005 to 2015 in California hospitals. 

Results showed that in 2005, timely angiography occurred for 50% of male patients and 35.7% of female patients with STEMI, and 45% of males and 33.1% of females with NSTEMI. In 2015, those rates improved to 76.7% of male patients and 66.8% of females with STEMI, and 56.3% of males and 45.9% of females with NSTEMI. 

Timely access to angiography is defined for this study as treatment on the day of hospital admission for STEMI patients and within three days of admission for NSTEMI patients. Angiography is a diagnostic process that involves an x-ray of dye injected into blood vessels to assess narrowing or blockage in veins or arteries. 

The proportion of patients who received timely treatment increased and mortality decreased over time for men and women. However, while gaps in treatment and outcomes between genders narrowed over time, these disparities persisted over the course of the years analyzed. 

It is striking that female patients received timely treatment for NSTEMI in 2015 at rates lower than males measured in 2006, the authors said. Females treated for STEMI in 2015 received timely treatment at lower rates than males did in 2010. 

These disparities also exist along racial lines. The authors note that Black, Hispanic, and Asian patients were less likely as white patients to undergo timely angiography, with minimal changes over time. 

“Some of the factors influencing this pronounced treatment gap are insurance status, hospital characteristics and geography,” said Dr. Montoy. “But there are biases and social issues that challenge access to care and impact the treatment of women and patients of color with heart issues. These gaps should concern clinicians and patients because they can result in delayed care and lower the likelihood that some patients receive potentially lifesaving treatment.” 

For more information: www.acep.org 

Related Women's Heart Health Content: 

SCAI Releases Expert Consensus on Gender-specific Considerations in Myocardial Revascularization 

More Data Needed on Stroke Treatment and Outcomes by Gender 

Diagnostic Differences in Women’s Heart Health 

VIDEO: Differences in Cardiac Complications and Presentation Between Men and Women — Interview with Cindy Grines, M.D. 

DAIC's Women's Cardiovascular Health Channel 

VIDEO: How to Build a Successful Women’s Heart Center — Interview with Malissa Wood, M.D. 

VIDEO: Creating a Cardio-Obstetrics Team — Doreen DeFaria Yeh, M.D.


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now